Mechanisms Underlying the Impairment of Hippocampal Long-term Potentiation and Memory in Experimental Parkinson's Disease Materials and Methods Procedure for L-dopa Treatments Immunohistological Procedure Behavioural Procedure

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Distinct Roles of NR2A and NR2B Cytoplasmic Tails in Long-Term Potentiation

  2010cited by this paper
• Associative Learning and CA3–CA1 Synaptic Plasticity Are Impaired in D1R Null, Drd1a−/− Mice and in Hippocampal siRNA Silenced Drd1a Mice

  2010cited by this paper
• Genetic animal models of Parkinson's disease.

  2010cited by this paper
• SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease.

  2010cited by this paper
• The role of medial temporal lobe in retrieving spatial and nonspatial relations from episodic and semantic memory

  2009cited by this paper
• The neuropsychopharmacology of fronto-executive function: monoaminergic modulation.

  2009cited by this paper
• Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.

  2009cited by this paper
• Distinct Hippocampal and Basal Ganglia Contributions to Probabilistic Learning and Reversal

  2009cited by this paper
• What is remembered? Role of attention on the encoding and retrieval of hippocampal representations

  2009cited by this paper
• Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy.

  2009cited by this paper
• Dopamine Controls Persistence of Long-Term Memory Storage

  2009cited by this paper
• Decreased NR2B Subunit Synaptic Levels Cause Impaired Long-Term Potentiation But Not Long-Term Depression

  2009cited by this paper
• D1 but not D5 dopamine receptors are critical for LTP, spatial learning, and LTP-Induced arc and zif268 expression in the hippocampus.

  2008cited by this paper
• Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease.

  2008cited by this paper
• Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis

  2008cited by this paper
• Synaptic plasticity, dopamine and Parkinson's disease: one step ahead.

  2008cited by this paper
• l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation.

  2008cited by this paper
• The hippocampal CA1 region and dentate gyrus differentiate between environmental and spatial feature encoding through long-term depression.

  2008cited by this paper
• Hippocampal head atrophy predominance in Parkinson’s disease with hallucinations and with dementia

  2008cited by this paper
• Pruning and loss of excitatory synapses by the parkin ubiquitin ligase

  2008cited by this paper
• Rapid bidirectional switching of synaptic NMDA receptors.

  2007cited by this paper
• Activation of NR2B-containing NMDA receptors is not required for NMDA receptor-dependent long-term depression.

  2007cited by this paper
• The medial prefrontal cortex determines the accumbens dopamine response to stress through the opposing influences of norepinephrine and dopamine.

  2007cited by this paper
• Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus.

  2007cited by this paper
• Dopamine-mediated regulation of corticostriatal synaptic plasticity.

  2007cited by this paper
• A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance.

  2006cited by this paper
• Dopamine D1/D5 Receptors Gate the Acquisition of Novel Information through Hippocampal Long-Term Potentiation and Long-Term Depression

  2006cited by this paper
• Pathological Changes in Dopaminergic Nerve Cells of the Substantia Nigra and Olfactory Bulb in Mice Transgenic for Truncated Human α-Synuclein(1–120): Implications for Lewy Body Disorders

  2006cited by this paper
• A Critical Interaction between NR2B and MAGUK in l-DOPA Induced Dyskinesia

  2006cited by this paper
• Hippocampal neuron and glial cell numbers in Parkinson's disease—A stereological study

  2006cited by this paper
• Cerebral atrophy and its relation to cognitive impairment in Parkinson disease

  2005cited by this paper
• Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study.

  2005cited by this paper
• ReviewThe Hippocampal-VTA Loop : Controlling the Entry of Information into Long-Term Memory

  2005cited by this paper
• Late-associativity, synaptic tagging, and the role of dopamine during LTP and LTD.

  2004cited by this paper
• Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson’s disease is related to cognitive impairment

  2004cited by this paper
• Novel spatial arrangements of familiar visual stimuli promote activity in the rat hippocampal formation but not the parahippocampal cortices: a c-fos expression study.

  2004cited by this paper
• Role of NMDA Receptor Subtypes in Governing the Direction of Hippocampal Synaptic Plasticity

  2004cited by this paper
• Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia

  2003cited by this paper
• Altered Glucocorticoid Rhythm Attenuates the Ability of a Chronic SSRI to Elevate Forebrain 5-HT: Implications for the Treatment of Depression

  2003cited by this paper
• Altered short-term hippocampal synaptic plasticity in mutant &agr;-synuclein transgenic mice

  2003cited by this paper
• Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3‐nitropropionic acid: implications for Huntington's disease

  2003cited by this paper
• Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions

  2002cited by this paper
• A Hippocampal NR2B Deficit Can Mimic Age-Related Changes in Long-Term Potentiation and Spatial Learning in the Fischer 344 Rat

  2002cited by this paper
• Mechanisms of cognitive set flexibility in Parkinson's disease.

  2001cited by this paper
• Storage, recall, and novelty detection of sequences by the hippocampus: Elaborating on the SOCRATIC model to account for normal and aberrant effects of dopamine

  2001cited by this paper
• Dopamine D5 receptor immunolocalization in rat and monkey brain

  2000cited by this paper
• Dramatic brain aminergic deficit in a genetic mouse model of phenylketonuria

  2000cited by this paper
• Genetic enhancement of learning and memory in mice

  1999cited by this paper
• The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

  1999cited by this paper
• The pharmacology of mesocortical dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain.

  1998cited by this paper
• The dopaminergic mesencephalic projections to the hippocampal formation in the rat.

  1997cited by this paper
• Burst activity of ventral tegmental dopamine neurons is elicited by sensory stimuli in the awake cat.

  1997cited by this paper
• D1/D5 Dopamine Receptor Activation Increases the Magnitude of Early Long-Term Potentiation at CA1 Hippocampal Synapses

  1996cited by this paper
• D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus.

  1995cited by this paper
• The effect of dopaminergic D1 receptor blockade during tetanization on the expression of long-term potentiation in the rat CA1 region in vitro.

  1991cited by this paper
• Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization

  1989cited by this paper
• ippocampal Synaptic Plasticity , Memory , and pilepsy : Effects of Long-Term Valproic Acid Treatment

  year unknowncited by this paper

• Synaptic mechanisms underlying onset and progression of memory deficits caused by hippocampal and midbrain synucleinopathy

  2023cites this paper
• Carrier-free quercetin nanomedicine blocks NLRP3 deubiquitination and TXNIP recruitment for Parkinson’s disease therapy

  2023cites this paper
• Spatial Transcriptome Profiling of Mouse Hippocampal Single Cell Microzone in Parkinson’s Disease

  2023cites this paper
• Dose and time-dependence of acute intermittent theta-burst stimulation on hippocampus-dependent memory in parkinsonian rats

  2023influential citation
• Updates on the Physiopathology of Group I Metabotropic Glutamate Receptors (mGluRI)-Dependent Long-Term Depression

  2023cites this paper
• Dynamic physiological α-synuclein S129 phosphorylation is driven by neuronal activity

  2023cites this paper
• Mechanisms of Functioning of the Connectome Including the Neocortex, Hippocampus, Basal Ganglia, Cerebellum, and Thalamus

  2022cites this paper
• Changes in the Neuronal Architecture of the Hippocampus in a 6-Hydroxydopamine-Lesioned Rat Model of Parkinson Disease

  2022cites this paper
• 2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1 Receptor for Parkinson’s Disease

  2022cites this paper
• Hippocampal Functional Connectivity in Parkinson’s Disease

  2022cites this paper
• Activation and blockade of 5-HT4 receptors in the dorsal hippocampus enhance working and hippocampus-dependent memories in the unilateral 6-hydroxydopamine lesioned rats.

  2022cites this paper
• Linking α-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson’s disease

  2022cites this paper
• Regulation and function of elF2B in neurological and metabolic disorders

  2022cites this paper
• Structural Plasticity of the Hippocampus in Neurodegenerative Diseases

  2022cites this paper
• Nano-MgO composites containing plasmid DNA to silence SNCA gene displays neuroprotective effects in Parkinson's rats induced by 6-hydroxydopamine.

  2022cites this paper
• The effects of neurosteroid allopregnanolone on synaptic dysfunction in the hippocampus in experimental parkinsonism rats: An electrophysiological and molecular study.

  2022cites this paper
• The involvement of TRPM2 on the MPP+-induced oxidative neurotoxicity and apoptosis in hippocampal neurons from neonatal mice: protective role of resveratrol

  2022cites this paper
• Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson’s Disease

  2021cites this paper
• The involvement of ADAR1 in Antidepressant Action by Regulating BDNF via miR-432.

  2021cites this paper
• Experimental Dopamine Reuptake Inhibitors in Parkinson’s Disease: A Review of the Evidence

  2021cites this paper
• Neuro-Immune Cross-Talk in the Striatum: From Basal Ganglia Physiology to Circuit Dysfunction

  2021cites this paper
• Fluoxetine tunes the abnormal hippocampal oscillations in association with cognitive impairments in 6-OHDA lesioned rats.

  2021cites this paper
• Moderating Effects of BDNF Genetic Variants and Smoking on Cognition in PTSD Veterans

  2021cites this paper
• Effects of Alpha-Synuclein Targeted Antisense Oligonucleotides on Lewy Body-Like Pathology and Behavioral Disturbances Induced by Injections of Pre-Formed Fibrils in the Mouse Motor Cortex

  2021cites this paper
• Basal Synaptic Transmission and Long-Term Plasticity at CA3-CA1 Synapses Are Unaffected in Young Adult PINK1-Deficient Rats

  2021cites this paper
• Potential protective role of astrocytes in the pathogenesis of astrocyte-mediated synaptic plasticity of Parkinson's disease.

  2021cites this paper
• Neuropsychiatric and Cognitive Deficits in Parkinson’s Disease and Their Modeling in Rodents

  2021cites this paper
• Hippocampal network dysfunction as a mechanism of early-onset dementia after preeclampsia and eclampsia.

  2020cites this paper
• Effect of Bromelain on BDNF level and memory deficit following intra-medial forebrain bundle 6-OHDA injection in rat model of Parkinsonism

  2020cites this paper
• Pathological α-synuclein triggers synaptic NMDA receptor dysfunction through altered trafficking

  2020cites this paper
• Apelin-13 prevents hippocampal synaptic plasticity impairment in Parkinsonism rats.

  2020cites this paper
• Transplanted Wharton`s jelly mesenchymal stem cells improve memory and brain hippocampal electrophysiology in rat model of Parkinson's disease.

  2020cites this paper
• Intranasal insulin ameliorates cognitive impairment in a rat model of Parkinson's disease through Akt/GSK3β signaling pathway.

  2020cites this paper
• The effect of chronic neuropeptide-S treatment on non-motor parameters in experimental model of Parkinson’s disease

  2020cites this paper
• Modelling cognitive deficits in Parkinson's disease: Is CA2 a gateway for hippocampal synucleinopathy?

  2020cites this paper
• Modeling Parkinson’s Disease With the Alpha-Synuclein Protein

  2020cites this paper
• Small dose of L-dopa/Benserazide Hydrochloride improved sepsis-induced neuroinflammation and long-term cognitive dysfunction in sepsis mice.

  2020cites this paper
• Serum levels of glial cell line‐derived neurotrophic factor and multiple neurotransmitters: In relation to cognitive performance in Parkinson's disease with mild cognitive impairment

  2019cites this paper
• The Relevance of Insulin Action in the Dopaminergic System

  2019cites this paper
• Selegiline Recovers Synaptic Plasticity in the Medial Prefrontal Cortex and Improves Corresponding Depression-Like Behavior in a Mouse Model of Parkinson’s Disease

  2019cites this paper
• A Gutsy Move for Cell-Based Regenerative Medicine in Parkinson’s Disease: Targeting the Gut Microbiome to Sequester Inflammation and Neurotoxicity

  2019cites this paper
• The role of MAPK signaling pathway in selenium amelioration of high fat/high cholesterol diet-induced tauopathy in rats.

  2019cites this paper
• Gutting the brain of inflammation: A key role of gut microbiome in human umbilical cord blood plasma therapy in Parkinson's disease model

  2019cites this paper
• Serotonin1A receptors in the dorsal hippocampus regulate working memory and long-term habituation in the hemiparkinsonian rats.

  2019cites this paper
• The Role of NOX4 in Parkinson’s Disease with Dementia

  2019cites this paper
• Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease

  2019cites this paper
• Voltage-Gated Sodium Channels Are Involved in Cognitive Impairments in Parkinson's Disease- like Rats.

  2019cites this paper
• A comprehensive review of genetic and epigenetic mechanisms that regulate BDNF expression and function with relevance to major depressive disorder

  2018cites this paper
• The role of mild treadmill exercise on spatial learning and memory and motor activity in animal models of ibotenic acid-induced striatum lesion

  2018cites this paper
• Critical appraisal of pathology transmission in the &agr;‐synuclein fibril model of Lewy body disorders

  2018cites this paper
• Stem Cell Therapy: Repurposing Cell-Based Regenerative Medicine Beyond Cell Replacement.

  2018cites this paper
• α‐Synuclein Oligomers: A Study in Diversity

  2017cites this paper
• Pramipexole restores depressed transmission in the ventral hippocampus following MPTP-lesion

  2017cites this paper
• Cell Therapy in Parkinson's Disease: Host Brain Repair Machinery Gets a Boost From Stem Cell Grafts

  2017cites this paper
• The histamine H3 receptor antagonist thioperamide rescues circadian rhythm and memory function in experimental parkinsonism

  2017cites this paper
• Reduced CA2–CA3 Hippocampal Subfield Volume Is Related to Depression and Normalized by l-DOPA in Newly Diagnosed Parkinson’s Disease

  2017cites this paper
• The Functional and Molecular Properties, Physiological Functions, and Pathophysiological Roles of GluN2A in the Central Nervous System

  2017cites this paper
• Endogenous repair mechanisms enhanced in Parkinson's disease following stem cell therapy

  2017cites this paper
• The Effects of Mild Forced Treadmill Exercise and GABA-B Agonist on Locomotor Activity and Anxiety-Behavior in Rats with Striatum Dysfunction

  2017cites this paper
• Environmental Enrichment Repairs Structural and Functional Plasticity in the Hippocampus

  2017cites this paper
• Deterioro cognitivo asociado a la patología parkinsoniana: el rol del hipocampo

  2016cites this paper
• Activation and blockade of serotonin6 receptors in the dorsal hippocampus enhance T maze and hole-board performance in a unilateral 6-hydroxydopamine rat model of Parkinson's disease.

  2016cites this paper
• Subtle alterations of excitatory transmission are linked to presynaptic changes in the hippocampus of PINK1‐deficient mice

  2016cites this paper
• Chronic early postnatal scream sound stress induces learning deficits and NMDA receptor changes in the hippocampus of adult mice

  2016cites this paper
• Dopaminergic lesioning impairs adult hippocampal neurogenesis by distinct modification of α‐synuclein

  2016cites this paper
• Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis

  2016cites this paper
• Exogenous Alpha-Synuclein Alters Pre- and Post-Synaptic Activity by Fragmenting Lipid Rafts

  2016cites this paper
• Toxin-Induced Experimental Models of Learning and Memory Impairment

  2016cites this paper
• Impact of Increased Astrocyte Expression of IL-6, CCL2 or CXCL10 in Transgenic Mice on Hippocampal Synaptic Function

  2016cites this paper
• Network and Pathway-Based Analyses of Genes Associated with Parkinson’s Disease

  2016cites this paper
• Combined Diffusion Tensor Imaging and Arterial Spin Labeling as Markers of Early Parkinson’s disease

  2016cites this paper
• Study of the transcriptional regulation of α-synuclein

  2015cites this paper
• Long-term treatment with L-DOPA or pramipexole affects adult neurogenesis and corresponding non-motor behavior in a mouse model of Parkinson's disease.

  2015cites this paper
• Changes in actin dynamics and F-actin structure both in synaptoneurosomes of LRRK2(R1441G) mutant mice and in primary human fibroblasts of LRRK2(G2019S) mutation carriers.

  2015cites this paper
• Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease.

  2015cites this paper
• Heterogeneity of the midbrain dopamine system

  2015cites this paper
• MPTP‐induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF‐TrkB pathway

  2015cites this paper
• Hippocampal function is compromised in an animal model of multiple sclerosis.

  2015cites this paper
• The Benefits of Exercise on Structural and Functional Plasticity in the Rodent Hippocampus of Different Disease Models

  2015cites this paper
• Genetic contribution of catechol‐O‐methyltransferase in hippocampal structural and functional changes of female migraine sufferers

  2015cites this paper
• Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson's disease rat.

  2014cites this paper
• The psychopharmacological effects of blackcurrant phytochemicals in humans

  2014cites this paper
• Multifunctional Effects of Mangosteen Pericarp on Cognition in C57BL/6J and Triple Transgenic Alzheimer's Mice

  2014cites this paper
• Cognitive impairment and dentate gyrus synaptic dysfunction in experimental parkinsonism.

  2014cites this paper
• Alteration of epigenetic program to recover memory and alleviate neurodegeneration: prospects of multi-target molecules.

  2014cites this paper
• SINTOMAS NÃO MOTORES NA DOENÇA DE PARKINSON: MODELO DE LESÃO INTRAESTRIATAL POR 6-OHDA EM CAMUNDONGOS

  2014cites this paper
• Effect of nigranoic acid on Ca²⁺ influx and its downstream signal mechanism in NGF-differentiated PC12 cells.

  2014cites this paper
• l-DOPA reverses the impairment of Dentate Gyrus LTD in experimental parkinsonism via β-adrenergic receptors.

  2014cites this paper
• Environmental enrichment restores CA1 hippocampal LTP and reduces severity of seizures in epileptic mice.

  2014cites this paper
• Neuroprotective effects of swimming training in a mouse model of Parkinson's disease induced by 6-hydroxydopamine.

  2014cites this paper
• Ventral Tegmental Area Inactivation Suppresses the Expression of CA1 Long Term Potentiation in Anesthetized Rat

  2013cites this paper
• New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease.

  2013cites this paper
• Uncoupling PSD-95 Interactions Leads to Rapid Recovery of Cortical Function after Focal Stroke

  2013cites this paper
• Mechanisms underlying synaptic vulnerability and degeneration in neurodegenerative disease

  2013cites this paper
• Impact of comorbidities on the treatment of chronic myeloid leukemia with tyrosine-kinase inhibitors

  2013cites this paper
• Chronic treatment with simvastatin affects cannabinoid receptor type 1 and muscarinic receptors type 2/4 in different brain regions among sham and 6-hydroxydopamine lesioned rats

  2013cites this paper
• The identification of dysfunctional crosstalk of pathways in Parkinson disease.

  2013cites this paper
• Preclinical Evaluation of Water-Soluble Coenzyme Q10 for Therapeutic Treatment of Parkinson's Disease

  2012cites this paper
• Dysregulations of the glutamatergic system in the 6-OHDA model of Parkinson ’ s disease

  2012cites this paper